BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Greenwell AA, Gopal K, Ussher JR. Myocardial Energy Metabolism in Non-ischemic Cardiomyopathy. Front Physiol 2020;11:570421. [PMID: 33041869 DOI: 10.3389/fphys.2020.570421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Schwartz B, Gjini P, Gopal DM, Fetterman JL. Inefficient Batteries in Heart Failure. JACC: Basic to Translational Science 2022. [DOI: 10.1016/j.jacbts.2022.03.017] [Reference Citation Analysis]
2 Zhang X, Zhang Y, Sun A, Ge J. The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential. Genes Dis 2022;9:959-72. [PMID: 35685463 DOI: 10.1016/j.gendis.2021.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ravi R, Fernandes Silva L, Vangipurapu J, Maria M, Raivo J, Helisalmi S, Laakso M. Metabolite Signature in the Carriers of Pathogenic Genetic Variants for Cardiomyopathy: A Population-Based METSIM Study. Metabolites 2022;12:437. [DOI: 10.3390/metabo12050437] [Reference Citation Analysis]
4 Akita K, Kikushima K, Ikoma T, Islam A, Sato T, Yamamoto T, Kahyo T, Setou M, Maekawa Y. The association between the clinical severity of heart failure and docosahexaenoic acid accumulation in hypertrophic cardiomyopathy. BMC Res Notes 2022;15:139. [PMID: 35421986 DOI: 10.1186/s13104-022-06023-1] [Reference Citation Analysis]
5 Kong Q, Gu J, Lu R, Huang C, Hu X, Wu W, Lin D. NMR-Based Metabolomic Analysis of Sera in Mouse Models of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy. Biomolecules 2022;12:112. [DOI: 10.3390/biom12010112] [Reference Citation Analysis]
6 Shao-Mei W, Li-Fang Y, Li-Hong W. Traditional Chinese medicine enhances myocardial metabolism during heart failure. Biomed Pharmacother 2021;146:112538. [PMID: 34922111 DOI: 10.1016/j.biopha.2021.112538] [Reference Citation Analysis]
7 Elezaby A, Parikh VN, Nayor M. Iron Deficiency as a Potential Modulator of Subclinical Deficiencies in Cardiac Performance and Exercise Capacity. J Card Fail 2021;27:822-4. [PMID: 34246431 DOI: 10.1016/j.cardfail.2021.04.018] [Reference Citation Analysis]
8 Greenwell AA, Gopal K, Altamimi TR, Saed CT, Wang F, Tabatabaei Dakhili SA, Ho KL, Zhang L, Eaton F, Kruger J, Al Batran R, Lopaschuk GD, Oudit GY, Ussher JR. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation. Am J Physiol Heart Circ Physiol 2021;320:H2255-69. [PMID: 33929899 DOI: 10.1152/ajpheart.00873.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Karwi QG, Ho KL, Pherwani S, Ketema EB, Sun QY, Lopaschuk GD. Concurrent diabetes and heart failure: interplay and novel therapeutic approaches. Cardiovasc Res 2021:cvab120. [PMID: 33783483 DOI: 10.1093/cvr/cvab120] [Reference Citation Analysis]